PET-CT with Gallium 68 (DOTATATE) Doctors Abroad — Page 2

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center. He uses diagnostic results from Gallium 68 DOTATATE scans to plan cancer treatments.

• Trained at the Gülhane Military Medical Academy as an oncology expert
• Specializes in systemic therapies including immunotherapy and targeted therapy
• Focused on treating lung, liver, pancreatic, and urogenital cancers
• Member of the Turkish Medical Oncology Society
• Member of the Turkish Lung Cancer Society

Professor Aksoy is an Assistant Professor at Cerrahpaşa Medical Faculty. He leads specialized imaging and interventional radiology services at Hisar Hospital Intercontinental.

• Expert in PET-CT with Gallium 68 diagnostics at a high-volume medical center
• Resident-trained at Istanbul University Cerrahpaşa Medical Faculty – a top Turkish institution
• Specializes in interventional radiology using imaging guidance for minimally invasive procedures
• Member of the European Society of Radiology which sets high imaging standards
• Presented academic research at 13 national and international medical congresses

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Professor Seref Komurcu is an ESMO-certified oncologist at Anadolu Medical Center. He specializes in treating neuroendocrine tumors that require PET-CT with Gallium 68 for staging.

• Authored over 110 scientific papers on cancer treatment
• Holds an ECFMG certificate from the United States
• Taught as a professor at Gulhane Military Medical Academy
• Treats neuroendocrine tumors of the pancreas and adrenal glands
• Member of the American Society of Clinical Oncology (ASCO)

Dr. Sezer Saglam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating gastrointestinal and breast cancers. His research on rectal cancer timing has influenced global treatment protocols. Dr. Saglam develops personalized therapy plans using targeted medicine and precision techniques.

• Nominated for the International Best Researcher Award for work on liver cancer.
• Leads clinical trials focused on targeted therapies and precision oncology.
• Member of the American Society of Clinical Oncology (ASCO).
• Certified by the European Society for Medical Oncology (ESMO).

Professor Christoph Zielinski leads the Vienna Cancer Center. He uses PET-CT with Gallium 68 to guide personalized immunotherapy and targeted cancer treatments.

• Medical Director of the International Oncology Center at Wiener Privatklinik
• Authored over 600 scientific papers on oncology and tumor biology
• Former Head of Oncology at Vienna General Hospital
• Founder of the Comprehensive Cancer Center Vienna
• Member of the European Society for Medical Oncology

Professor Wolfgang Köstler is the Deputy Head of Oncology at the Medical University of Vienna. He uses advanced PET-CT with Gallium 68 to guide precision oncology and targeted therapies.

• Trained at Memorial Sloan-Kettering Cancer Center – a global leader in cancer care
• Specializes in molecular oncology to design treatments based on a patient's unique biology
• Senior Consultant at Wiener Privatklinik providing personalized systemic cancer treatments
• Holds a degree in molecular biology from the Weizmann Institute of Science
• Expert in treating complex gastrointestinal tumors and rare sarcomas

Forbes Israel recognized Dr. Blachar Arye as one of the country's top physicians. This PET-CT specialist leads diagnostic imaging at Sourasky Medical Center.

• Fellowship trained in abdominal imaging at the University of Pittsburgh Medical Center
• Completed advanced CT colonography training at Harvard University and Beth-Israel-Deaconess Hospital
• Received the Magna Cum Lauda for research on liver transplant diagnostic imaging
• Elected Fellow of the European Society of Gastrointestinal and Abdominal Radiology
• Diagnostic radiology residency completed at Hadassah Medical Center

Professor Einat Even-sapir directs the Nuclear Medicine Department at Sourasky Medical Center. She specializes in using PET-CT with Gallium 68 to detect neuroendocrine tumors.

• Heads the nuclear medicine unit at Ichilov – one of Israel's largest hospitals
• Uses hybrid imaging – combines scanning types like PET and CT for higher accuracy
• Holds a PhD in medical sciences from the Israel Institute of Technology
• Completed specialized medical training at Dalhousie University in Canada
• Uses precision molecular imaging to identify small or hidden lesions

Dr. Viola Fox is the Chief Physician at the Clinic for Oncology in Solingen. She is a leading expert in drug therapy for tumors in Germany and Europe. Dr. Fox holds a qualification in specialist genetics and conducts molecular biology research. She treats complex cases at a certified interdisciplinary cancer center.

• Member of the American Association for Cancer Research.
• Specializes in immunotherapy, targeted therapy, and molecular diagnostics.
• Treats hematological diseases, including lymphoma, leukemia, and myeloma.
• Works at Städtisches Klinikum Solingen, a clinic ranked among the top in Germany.

Professor Sebastian Keil serves as the Chief Physician for Diagnostic and Interventional Radiology at Academic Hospital Solingen. He specializes in using PET-CT with Gallium 68 to detect neuroendocrine tumors.

• Graduated with honors and holds a doctoral degree in radiology from Hamburg-Alton Clinic
• Trained under Prof. Rolf W. Günther, a world pioneer in interventional radiology techniques
• Performs high-precision cross-sectional imaging using CT and MRI for complex cancer cases
• Uses targeted imaging to guide minimally invasive treatments for liver and pancreatic tumors
• Former leading doctor at the Diagnostic and Interventional Radiology Clinic under Prof. Kuhl

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Gul Alco is a radiation oncologist and Professor at Medipol Acibadem District Hospital in Istanbul. She excels in treating complex cases, including stage 4 lung and liver cancers. Dr. Alco utilizes the CyberKnife and Da Vinci robotic systems for precise tumor targeting. She works at a JCI-accredited facility known for its high safety standards.

• Specializes in brachytherapy and high-intensity focused ultrasound ablation (HIFU).
• Performs radiofrequency ablation and proton-beam therapy for various malignancies.
• Treats pancreatic, breast, ovarian, and brain cancers using targeted radiation.
• Expert in nuclear medicine diagnostics, including PET-CT with Gallium 68.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mesut Okur is a professor and chief physician at Medipol University Pendik Hospital in Istanbul. He specializes in pediatric health and diseases, with a focus on internal medical sciences. Dr. Okur has published over 25 international peer-reviewed articles. He treats children for conditions ranging from congenital heart defects to thyroid disorders.

• Published research on Down syndrome, pediatric brucellosis, and neonatal health.
• Supervises specialized medical theses on allergic rhinitis and pediatric diabetes.
• Practices at a hospital holding a Healthcare Quality Standards Certificate of 95.4%.
• Performed clinical research on pediatric voiding dysfunction and enuresis.